MapLight Therapeutics, Inc.

NASDAQ:MPLT

Biotechnology

Healthcare
$6.65 +3.11%

+$0.39 today

Market cap
$283.41M
Beta
2.65
P/E (TTM)
-2.8
EPS (TTM)
-$4.41
52W Low $9.10High $40.43

Volume 0.42M

Average 0.73M

Balance Sheet

Inspect the capital base behind the business.

Assets

$479.51M

FY 2025 · Annual

+250.2% YoY

Liabilities

$21.14M

FY 2025 · Annual

-2.7% YoY

Equity

$458.37M

FY 2025 · Annual

+297.9% YoY

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents27.67M79.77M38.25M46.73M
Short-term Investments0070.54M258.37M
Net Receivables0000
Inventory0000
Other Current Assets4.37M0019.57M
Total Current Assets32.03M83.6M114.6M324.67M
Property, Plant & Equipment (Net)7.12M6.59M7.56M6.58M
Goodwill0000
Intangible Assets0000
Long-term Investments234K1.22M11.59M148.2M
Tax Assets0000
Other Non-current Assets234K234K3.17M59K
Total Non-current Assets7.36M7.81M22.31M154.84M
Total Assets39.39M91.41M136.92M479.51M
Account Payables3.6M3.25M1.91M0
Short-term Debt348K495K778K891K
Tax Payables0000
Deferred Revenue5.86M4.2M3.24M0
Other Current Liabilities1.34M4M5.98M9.18M
Total Current Liabilities12.6M14.7M15.92M16.23M
Long-term Debt0000
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities0000
Total Non-current Liabilities5.92M5.43M5.8M4.91M
Total Liabilities18.52M20.13M21.72M21.14M
Common Stock0005K
Retained Earnings(66.08M)(121.79M)(199.37M)(360.52M)
Accumulated OCI00163K(228K)
Other Stockholders Equity(1)000
Minority Interest0000
Total Equity20.87M71.28M115.2M458.37M
Total Debt6.27M5.92M6.58M5.8M
Net Debt(21.39M)(73.85M)(31.67M)(40.93M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$55.7M
Short-term Investments$254.4M
Other Current$17.1M
Total Current Assets$327.2M
PP&E (Net)$6.2M
Long-term Investments$85.3M
Other Non-current$36.0K
Total Non-current Assets$91.6M
Total Assets$418.8M

Analysis

Selected assets total $418.8M for Latest. The largest visible component is Short-term Investments at $254.4M, about 60.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026

How much cash does MPLT have?

MapLight Therapeutics, Inc. (MPLT) reported $46.73M in cash and equivalents in fiscal 2025.

How much debt does MPLT carry?

MapLight Therapeutics, Inc. (MPLT) reported $5.80M of total debt, with net debt of -$40.93M.